NCT06040918View on ClinicalTrials.gov

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

October 4, 2023

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions

Healthy Subjects

Interventions

DRUG

N-803

fixed dose of 1 mg by subcutaneous (SC) injection

Trial Locations (1)

90245

Chan Soon-Shiong Institute for Medicine, El Segundo

Sponsors

Lead Sponsor

ImmunityBio, Inc.

All Listed Sponsors

lead

ImmunityBio, Inc.

INDUSTRY

NCT06040918 - Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis | Biotech Hunter | Biotech Hunter